Vanguard Fiduciary Trust
VVOS icon

Vanguard Fiduciary Trust’s Vivos Therapeutics VVOS Stock Holding History

Vanguard Fiduciary Trust’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Sell
23,432
-7,400
-24% -$5.8K ﹤0.01% 4036
2026
Q1 		$36.4K Buy
+30,832
New +$49.4K ﹤0.01% 3876

Other funds holding VVOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Vanguard Fiduciary Trust's VVOS Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Vivos Therapeutics (VVOS) stake by 24% in Q2 2026, selling an estimated $5.8K and leaving 23,432 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4036.

Vanguard Fiduciary Trust first reported a position in VVOS in Q1 2026 and has held it in 2 quarters since. The position peaked at $36.4K in Q1 2026. 23 funds tracked by Wall St. Rank hold VVOS as of Q2 2026.

  • Vanguard Fiduciary Trust held 23,432 shares of Vivos Therapeutics worth $10.7K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 7,400 Vivos Therapeutics shares in Q2 2026, an estimated $5.8K.
  • Vivos Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4036 holding.
  • Vanguard Fiduciary Trust first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Vivos Therapeutics position peaked at $36.4K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.